{"id":11217,"date":"2024-07-16T15:35:48","date_gmt":"2024-07-16T12:35:48","guid":{"rendered":"https:\/\/ivmed.agency\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/"},"modified":"2024-07-16T15:36:35","modified_gmt":"2024-07-16T12:36:35","slug":"le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite","status":"publish","type":"post","link":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/","title":{"rendered":"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&rsquo;infertilit\u00e9"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Le traitement de l&rsquo;infertilit\u00e9 peut parfois \u00eatre tr\u00e8s compliqu\u00e9 et prendre beaucoup de temps, en particulier lorsque la grossesse ne se produit pas malgr\u00e9 tous les efforts de la patiente et des m\u00e9decins. Les cas o\u00f9 les ovocytes et les embryons sont de mauvaise qualit\u00e9 sont consid\u00e9r\u00e9s comme particuli\u00e8rement difficiles \u00e0 surmonter. En outre, ni les m\u00e9decins ni les patients ne peuvent identifier et pr\u00e9venir \u00e0 l&rsquo;avance un certain nombre de probl\u00e8mes susceptibles de survenir au cours du traitement.<\/p>\n\n<h2 class=\"wp-block-heading\">Qu&rsquo;est-ce que le transfert nucl\u00e9aire ?<\/h2>\n\n<p class=\"wp-block-paragraph\">Le transfert nucl\u00e9aire (TN) est une nouvelle approche du traitement de la st\u00e9rilit\u00e9, qui consiste \u00e0 transf\u00e9rer le mat\u00e9riel nucl\u00e9aire de la patiente dans le cytoplasme d&rsquo;un ovule de donneuse. La logique qui sous-tend cette m\u00e9thode est que certains facteurs n\u00e9gatifs peuvent \u00eatre li\u00e9s au cytoplasme de l&rsquo;ovocyte et peuvent \u00eatre surmont\u00e9s en rempla\u00e7ant le cytoplasme.<\/p>\n\n<p class=\"wp-block-paragraph\">Facteurs embryonnaires internes qui conduisent \u00e0 l&rsquo;arr\u00eat embryonnaire :<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Caract\u00e9ristiques de l&rsquo;expression g\u00e9n\u00e9tique<\/li>\n\n\n\n<li>Troubles de la quantit\u00e9 et de la fonction de l&rsquo;ADN mitochondrial<\/li>\n\n\n\n<li>Caract\u00e9ristiques de la m\u00e9thylation<\/li>\n\n\n\n<li>Petits ARN non codants<\/li>\n\n\n\n<li>Anomalies chromosomiques<\/li>\n\n\n\n<li>Profil m\u00e9tabolique de l&#8217;embryon<\/li>\n\n\n\n<li>Caract\u00e9ristiques morphologiques sp\u00e9cifiques, en particulier la vacuolisation<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">Le r\u00f4le des mitochondries dans les ovocytes<\/h2>\n\n<p class=\"wp-block-paragraph\">Les ovocytes poss\u00e8dent le plus grand nombre de mitochondries et de copies de l&rsquo;ADN mitochondrial (ADNmt) par rapport aux autres cellules du corps. Les mitochondries dans les ovocytes ont deux r\u00f4les principaux : r\u00e9pondre aux besoins m\u00e9taboliques de l&rsquo;ovocyte et r\u00e9guler l&rsquo;apoptose, tout en servant de r\u00e9servoir d&rsquo;ADNmt intact pour le d\u00e9veloppement futur de la prog\u00e9niture. Pendant le recrutement des follicules, la masse mitochondriale peut passer de 6000 copies d&rsquo;ADNmt \u00e0 200000, ce qui les rend plus vuln\u00e9rables aux mutations et aux d\u00e9l\u00e9tions.<\/p>\n\n<h2 class=\"wp-block-heading\">M\u00e9thodes de transfert nucl\u00e9aire<\/h2>\n\n<p class=\"wp-block-paragraph\">Il existe plusieurs m\u00e9thodes de transfert nucl\u00e9aire qui sont utilis\u00e9es avant et apr\u00e8s la f\u00e9condation :<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Avant la f\u00e9condation : Transfert de v\u00e9sicule germinale (GVT), Transfert de fuseau de division chromosomique (MIST | MIIST), Premier transfert de corps polaire (PB1GT)<\/li>\n\n\n\n<li>Apr\u00e8s la f\u00e9condation : Transfert du deuxi\u00e8me corps polaire (PB2GT), transfert pronucl\u00e9aire (PNT)<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">Exp\u00e9rience de la clinique IVMED<\/h2>\n\n<p class=\"wp-block-paragraph\">Parmi les patients ayant subi un transfert de fuseau de fission et de corps polaires (MS et PB1), l&rsquo;\u00e2ge moyen des patients est de 40,3 ans et le nombre moyen de tentatives de FIV-ICSI ant\u00e9rieures est de 3,3. Nous avons utilis\u00e9 99 ovocytes M II de patientes et 166 ovocytes M II de donneuses. La reconstruction a \u00e9t\u00e9 r\u00e9ussie dans 86 % des cas, avec un taux de fragmentation de 60 % et un taux de formation de blastocystes de 29 %.<\/p>\n\n<p class=\"wp-block-paragraph\">Les patients qui ont subi un transfert pronucl\u00e9aire (TPN) avaient un \u00e2ge moyen de 39,7 ans et le nombre moyen de tentatives d&rsquo;ICSI ant\u00e9rieures \u00e9tait de 3,8. Nous avons utilis\u00e9 185 ovocytes M II de patientes et 277 ovocytes M II de donneuses. La reconstruction a \u00e9t\u00e9 r\u00e9ussie dans 83,4 % des cas, le taux de fragmentation de la tige \u00e9tait de 72,2 % et le taux de formation de blastocystes \u00e9tait de 44 %.<\/p>\n\n<h2 class=\"wp-block-heading\">Conclusions<\/h2>\n\n<p class=\"wp-block-paragraph\">Dans certains cas, la reconstruction ovocytaire peut \u00eatre consid\u00e9r\u00e9e comme une alternative au don d&rsquo;ovocytes. Le choix d&rsquo;une technique sp\u00e9cifique d\u00e9pend du nombre et de la qualit\u00e9 des ovocytes, ainsi que de la situation clinique. Les maladies mitochondriales ne sont pas toujours une indication pour le transfert nucl\u00e9aire s&rsquo;il n&rsquo;existe pas de technologie permettant d&rsquo;\u00e9liminer compl\u00e8tement l&rsquo;ADNmt maternel. Les infirmi\u00e8res praticiennes sont moins efficaces pour les femmes plus \u00e2g\u00e9es. Chaque cas est unique et n\u00e9cessite une approche individuelle. L&rsquo;utilisation de la PN vous permet de tomber enceinte dans les cas o\u00f9 la FIV classique ne fonctionne pas.<\/p>\n\n<p class=\"wp-block-paragraph\">Aujourd&rsquo;hui, nous avons des naissances vivantes apr\u00e8s un tel traitement, ce qui est notre r\u00e9ussite commune avec nos patients !<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le transfert nucl\u00e9aire (TN) est une nouvelle approche du traitement de la st\u00e9rilit\u00e9, qui consiste \u00e0 transf\u00e9rer le mat\u00e9riel nucl\u00e9aire de la patiente dans le cytoplasme d&rsquo;un ovule de donneuse.  <\/p>\n","protected":false},"author":9,"featured_media":11205,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[219],"tags":[],"class_list":["post-11217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-sur-linfertilite"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&#039;infertilit\u00e9 - IVMED Family Agency<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&#039;infertilit\u00e9 - IVMED Family Agency\" \/>\n<meta property=\"og:description\" content=\"Le transfert nucl\u00e9aire (TN) est une nouvelle approche du traitement de la st\u00e9rilit\u00e9, qui consiste \u00e0 transf\u00e9rer le mat\u00e9riel nucl\u00e9aire de la patiente dans le cytoplasme d&#039;un ovule de donneuse.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/\" \/>\n<meta property=\"og:site_name\" content=\"IVMED Family Agency\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ivmed.agency\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-16T12:35:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-16T12:36:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1068\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oksana Yemets\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oksana Yemets\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/\"},\"author\":{\"name\":\"Oksana Yemets\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/person\\\/067b6631b18ef3fe481886cf7e1f67a2\"},\"headline\":\"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&rsquo;infertilit\u00e9\",\"datePublished\":\"2024-07-16T12:35:48+00:00\",\"dateModified\":\"2024-07-16T12:36:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/\"},\"wordCount\":686,\"publisher\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"articleSection\":[\"Blog sur l'infertilit\u00e9\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/\",\"name\":\"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l'infertilit\u00e9 - IVMED Family Agency\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"datePublished\":\"2024-07-16T12:35:48+00:00\",\"dateModified\":\"2024-07-16T12:36:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"contentUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/ivf-with-donor-sperm-lab-procedure.jpg\",\"width\":1600,\"height\":1068},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ivmed.agency\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infertility Blog\",\"item\":\"https:\\\/\\\/ivmed.agency\\\/category\\\/infertility-blog\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&#8217;infertilit\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#website\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/\",\"name\":\"In-Vitro Fertility Medicine and Surrogacy Programs. IVMED Clinic, Ukraine\",\"description\":\"High-quality IVF services and surrogacy\",\"publisher\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ivmed.agency\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#organization\",\"name\":\"IVMED Family Agency - IVF and Surrogacy Programs\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/ivmed-family-logo-RGB-gorizontal-1.png\",\"contentUrl\":\"https:\\\/\\\/ivmed.agency\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/ivmed-family-logo-RGB-gorizontal-1.png\",\"width\":1000,\"height\":256,\"caption\":\"IVMED Family Agency - IVF and Surrogacy Programs\"},\"image\":{\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ivmed.agency\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ivmed.agency\\\/#\\\/schema\\\/person\\\/067b6631b18ef3fe481886cf7e1f67a2\",\"name\":\"Oksana Yemets\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g\",\"caption\":\"Oksana Yemets\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l'infertilit\u00e9 - IVMED Family Agency","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/","og_locale":"fr_FR","og_type":"article","og_title":"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l'infertilit\u00e9 - IVMED Family Agency","og_description":"Le transfert nucl\u00e9aire (TN) est une nouvelle approche du traitement de la st\u00e9rilit\u00e9, qui consiste \u00e0 transf\u00e9rer le mat\u00e9riel nucl\u00e9aire de la patiente dans le cytoplasme d'un ovule de donneuse.","og_url":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/","og_site_name":"IVMED Family Agency","article_publisher":"https:\/\/www.facebook.com\/ivmed.agency","article_published_time":"2024-07-16T12:35:48+00:00","article_modified_time":"2024-07-16T12:36:35+00:00","og_image":[{"width":1600,"height":1068,"url":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","type":"image\/jpeg"}],"author":"Oksana Yemets","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Oksana Yemets","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#article","isPartOf":{"@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/"},"author":{"name":"Oksana Yemets","@id":"https:\/\/ivmed.agency\/#\/schema\/person\/067b6631b18ef3fe481886cf7e1f67a2"},"headline":"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&rsquo;infertilit\u00e9","datePublished":"2024-07-16T12:35:48+00:00","dateModified":"2024-07-16T12:36:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/"},"wordCount":686,"publisher":{"@id":"https:\/\/ivmed.agency\/#organization"},"image":{"@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#primaryimage"},"thumbnailUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","articleSection":["Blog sur l'infertilit\u00e9"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/","url":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/","name":"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l'infertilit\u00e9 - IVMED Family Agency","isPartOf":{"@id":"https:\/\/ivmed.agency\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#primaryimage"},"image":{"@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#primaryimage"},"thumbnailUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","datePublished":"2024-07-16T12:35:48+00:00","dateModified":"2024-07-16T12:36:35+00:00","breadcrumb":{"@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#primaryimage","url":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","contentUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2024\/07\/ivf-with-donor-sperm-lab-procedure.jpg","width":1600,"height":1068},{"@type":"BreadcrumbList","@id":"https:\/\/ivmed.agency\/fr\/le-transfert-nucleaire-une-nouvelle-approche-du-traitement-de-linfertilite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ivmed.agency\/fr\/"},{"@type":"ListItem","position":2,"name":"Infertility Blog","item":"https:\/\/ivmed.agency\/category\/infertility-blog\/"},{"@type":"ListItem","position":3,"name":"Le transfert nucl\u00e9aire : une nouvelle approche du traitement de l&#8217;infertilit\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/ivmed.agency\/#website","url":"https:\/\/ivmed.agency\/","name":"In-Vitro Fertility Medicine and Surrogacy Programs. IVMED Clinic, Ukraine","description":"High-quality IVF services and surrogacy","publisher":{"@id":"https:\/\/ivmed.agency\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ivmed.agency\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ivmed.agency\/#organization","name":"IVMED Family Agency - IVF and Surrogacy Programs","url":"https:\/\/ivmed.agency\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ivmed.agency\/#\/schema\/logo\/image\/","url":"https:\/\/ivmed.agency\/wp-content\/uploads\/2023\/03\/ivmed-family-logo-RGB-gorizontal-1.png","contentUrl":"https:\/\/ivmed.agency\/wp-content\/uploads\/2023\/03\/ivmed-family-logo-RGB-gorizontal-1.png","width":1000,"height":256,"caption":"IVMED Family Agency - IVF and Surrogacy Programs"},"image":{"@id":"https:\/\/ivmed.agency\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ivmed.agency"]},{"@type":"Person","@id":"https:\/\/ivmed.agency\/#\/schema\/person\/067b6631b18ef3fe481886cf7e1f67a2","name":"Oksana Yemets","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de9b5a37c7f9a87fdab1921bf6ab6d96a3f78cecfa1e0190aa8b25bb3aea97f1?s=96&d=mm&r=g","caption":"Oksana Yemets"}}]}},"_links":{"self":[{"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/posts\/11217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/comments?post=11217"}],"version-history":[{"count":1,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/posts\/11217\/revisions"}],"predecessor-version":[{"id":11218,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/posts\/11217\/revisions\/11218"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/media\/11205"}],"wp:attachment":[{"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/media?parent=11217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/categories?post=11217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ivmed.agency\/fr\/wp-json\/wp\/v2\/tags?post=11217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}